ID   GLO2_HUMAN              Reviewed;         308 AA.
AC   Q16775; A8K290; B4DP33; B4DRA7; E7EN93;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 2.
DT   22-JUL-2015, entry version 143.
DE   RecName: Full=Hydroxyacylglutathione hydrolase, mitochondrial;
DE            EC=3.1.2.6;
DE   AltName: Full=Glyoxalase II;
DE            Short=Glx II;
DE   Flags: Precursor;
GN   Name=HAGH; Synonyms=GLO2, HAGH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K.,
RA   Tufarelli C., Kearney L., Buckle V.J., Doggett N.A., Flint J.,
RA   Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2
RT   Mb of the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 37-308 (ISOFORMS 1/2).
RC   TISSUE=Liver;
RX   PubMed=8550579; DOI=10.1074/jbc.271.1.319;
RA   Ridderstroem M., Saccucci F., Hellman U., Bergman T., Principato G.,
RA   Mannervik B.;
RT   "Molecular cloning, heterologous expression, and characterization of
RT   human glyoxalase II.";
RL   J. Biol. Chem. 271:319-323(1996).
RN   [6]
RP   SUBCELLULAR LOCATION, ALTERNATIVE INITIATION, ALTERNATIVE SPLICING
RP   (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RX   PubMed=15117945; DOI=10.1074/jbc.M403470200;
RA   Cordell P.A., Futers T.S., Grant P.J., Pease R.J.;
RT   "The human hydroxyacylglutathione hydrolase (HAGH) gene encodes both
RT   cytosolic and mitochondrial forms of glyoxalase II.";
RL   J. Biol. Chem. 279:28653-28661(2004).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-229, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 49-308 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS AND ZINC IONS.
RC   TISSUE=Liver;
RX   PubMed=10508780; DOI=10.1016/S0969-2126(99)80174-9;
RA   Cameron A.D., Ridderstroem M., Olin B., Mannervik B.;
RT   "Crystal structure of human glyoxalase II and its complex with a
RT   glutathione thiolester substrate analogue.";
RL   Structure 7:1067-1077(1999).
CC   -!- FUNCTION: Thiolesterase that catalyzes the hydrolysis of S-D-
CC       lactoyl-glutathione to form glutathione and D-lactic acid.
CC   -!- CATALYTIC ACTIVITY: S-(2-hydroxyacyl)glutathione + H(2)O =
CC       glutathione + a 2-hydroxy carboxylate.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 2 Zn(2+) ions per subunit.;
CC   -!- PATHWAY: Secondary metabolite metabolism; methylglyoxal
CC       degradation; (R)-lactate from methylglyoxal: step 2/2.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:10508780}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion matrix.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16775-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16775-2; Sequence=VSP_037929;
CC         Note=Produced by alternative splicing. Also produced by
CC         alternative initiation at Met-49 of isoform 1.;
CC       Name=3;
CC         IsoId=Q16775-3; Sequence=VSP_055199, VSP_055200;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in liver and kidney.
CC       {ECO:0000269|PubMed:15117945}.
CC   -!- SIMILARITY: Belongs to the metallo-beta-lactamase superfamily.
CC       Glyoxalase II family. {ECO:0000305}.
CC   -!- CAUTION: Only one single gene encoding glyoxalase II has been
CC       identified in vertebrates. In yeast and higher plants, separate
CC       genes encode the cytosolic and mitochondrial forms of glyoxalase
CC       II. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH00840.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA62483.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK290155; BAF82844.1; -; mRNA.
DR   EMBL; AK298174; BAG60445.1; -; mRNA.
DR   EMBL; AK299173; BAG61219.1; -; mRNA.
DR   EMBL; AE006639; AAK61294.1; -; Genomic_DNA.
DR   EMBL; AC012180; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000840; AAH00840.1; ALT_INIT; mRNA.
DR   EMBL; BC002627; AAH02627.2; -; mRNA.
DR   EMBL; X90999; CAA62483.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10447.2; -. [Q16775-1]
DR   CCDS; CCDS32366.1; -. [Q16775-2]
DR   CCDS; CCDS66900.1; -. [Q16775-3]
DR   RefSeq; NP_001035517.1; NM_001040427.1. [Q16775-2]
DR   RefSeq; NP_001273178.1; NM_001286249.1. [Q16775-3]
DR   RefSeq; NP_005317.2; NM_005326.4. [Q16775-1]
DR   RefSeq; XP_011520772.1; XM_011522470.1. [Q16775-3]
DR   UniGene; Hs.157394; -.
DR   PDB; 1QH3; X-ray; 1.90 A; A/B=49-308.
DR   PDB; 1QH5; X-ray; 1.45 A; A/B=49-308.
DR   PDB; 2F50; Model; -; A=64-225.
DR   PDBsum; 1QH3; -.
DR   PDBsum; 1QH5; -.
DR   PDBsum; 2F50; -.
DR   ProteinModelPortal; Q16775; -.
DR   SMR; Q16775; 49-308.
DR   BioGrid; 109279; 5.
DR   IntAct; Q16775; 1.
DR   STRING; 9606.ENSP00000380514; -.
DR   BindingDB; Q16775; -.
DR   ChEMBL; CHEMBL2261; -.
DR   DrugBank; DB00143; Glutathione.
DR   PhosphoSite; Q16775; -.
DR   BioMuta; HAGH; -.
DR   DMDM; 257051015; -.
DR   MaxQB; Q16775; -.
DR   PaxDb; Q16775; -.
DR   PRIDE; Q16775; -.
DR   DNASU; 3029; -.
DR   Ensembl; ENST00000397353; ENSP00000380511; ENSG00000063854. [Q16775-2]
DR   Ensembl; ENST00000397356; ENSP00000380514; ENSG00000063854.
DR   Ensembl; ENST00000455446; ENSP00000406552; ENSG00000063854. [Q16775-3]
DR   GeneID; 3029; -.
DR   KEGG; hsa:3029; -.
DR   UCSC; uc002cmz.3; human. [Q16775-1]
DR   CTD; 3029; -.
DR   GeneCards; GC16M001845; -.
DR   HGNC; HGNC:4805; HAGH.
DR   HPA; CAB033531; -.
DR   HPA; HPA043041; -.
DR   HPA; HPA061143; -.
DR   MIM; 138760; gene+phenotype.
DR   neXtProt; NX_Q16775; -.
DR   PharmGKB; PA29179; -.
DR   eggNOG; COG0491; -.
DR   GeneTree; ENSGT00530000063033; -.
DR   HOGENOM; HOG000058041; -.
DR   HOVERGEN; HBG001152; -.
DR   InParanoid; Q16775; -.
DR   KO; K01069; -.
DR   OMA; HVKCLST; -.
DR   PhylomeDB; Q16775; -.
DR   TreeFam; TF105273; -.
DR   BRENDA; 3.1.2.6; 2681.
DR   SABIO-RK; Q16775; -.
DR   UniPathway; UPA00619; UER00676.
DR   EvolutionaryTrace; Q16775; -.
DR   GeneWiki; HAGH; -.
DR   GenomeRNAi; 3029; -.
DR   NextBio; 11990; -.
DR   PRO; PR:Q16775; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; Q16775; -.
DR   CleanEx; HS_HAGH; -.
DR   ExpressionAtlas; Q16775; baseline and differential.
DR   Genevisible; Q16775; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0004416; F:hydroxyacylglutathione hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:Ensembl.
DR   GO; GO:0006750; P:glutathione biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.60.15.10; -; 1.
DR   HAMAP; MF_01374; Glyoxalase_2; 1.
DR   InterPro; IPR001279; Beta-lactamas-like.
DR   InterPro; IPR017782; Hydroxyacylglutathione_Hdrlase.
DR   Pfam; PF00753; Lactamase_B; 1.
DR   PIRSF; PIRSF005457; Glx; 1.
DR   SMART; SM00849; Lactamase_B; 1.
DR   SUPFAM; SSF56281; SSF56281; 1.
DR   TIGRFAMs; TIGR03413; GSH_gloB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Alternative splicing; Complete proteome; Cytoplasm; Hydrolase;
KW   Metal-binding; Mitochondrion; Reference proteome; Transit peptide;
KW   Zinc.
FT   TRANSIT       1     13       Mitochondrion. {ECO:0000255}.
FT   CHAIN        14    308       Hydroxyacylglutathione hydrolase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000192342.
FT   REGION      191    193       Substrate binding.
FT   REGION      221    223       Substrate binding.
FT   REGION      297    300       Substrate binding.
FT   METAL       102    102       Zinc 1.
FT   METAL       104    104       Zinc 1.
FT   METAL       106    106       Zinc 2.
FT   METAL       107    107       Zinc 2.
FT   METAL       158    158       Zinc 1.
FT   METAL       182    182       Zinc 1.
FT   METAL       182    182       Zinc 2.
FT   METAL       221    221       Zinc 2.
FT   MOD_RES     116    116       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KB8}.
FT   MOD_RES     229    229       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES     229    229       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KB8}.
FT   VAR_SEQ       1     48       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037929.
FT   VAR_SEQ     146    236       GSLNVKCLATPCHTSGHICYFVSKPGGSEPPAVFTGDTLFV
FT                                AGCGKFYEGTADEMCKALLEVLGRLPPDTRVYCGHEYTINN
FT                                LKFARHVEP -> TPCLWLAAGSSMKGLRMRCVKLCWRSWA
FT                                GSPRTQESTVATSTPSTTSSLHATWSPAMPPSGRSWPGPRR
FT                                STASGSPQCHPPWQRSLPTTPS (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055199.
FT   VAR_SEQ     237    308       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055200.
FT   CONFLICT     67     67       D -> G (in Ref. 1; BAG60445).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       L -> P (in Ref. 1; BAG61219).
FT                                {ECO:0000305}.
FT   CONFLICT    202    202       K -> E (in Ref. 1; BAF82844).
FT                                {ECO:0000305}.
FT   STRAND       50     56       {ECO:0000244|PDB:1QH5}.
FT   TURN         57     59       {ECO:0000244|PDB:1QH5}.
FT   STRAND       60     67       {ECO:0000244|PDB:1QH5}.
FT   TURN         68     71       {ECO:0000244|PDB:1QH5}.
FT   STRAND       72     77       {ECO:0000244|PDB:1QH5}.
FT   HELIX        81     91       {ECO:0000244|PDB:1QH5}.
FT   STRAND       94     99       {ECO:0000244|PDB:1QH5}.
FT   HELIX       105    108       {ECO:0000244|PDB:1QH5}.
FT   HELIX       111    117       {ECO:0000244|PDB:1QH5}.
FT   STRAND      122    126       {ECO:0000244|PDB:1QH5}.
FT   STRAND      134    136       {ECO:0000244|PDB:1QH5}.
FT   STRAND      142    145       {ECO:0000244|PDB:1QH5}.
FT   STRAND      148    154       {ECO:0000244|PDB:1QH5}.
FT   STRAND      157    159       {ECO:0000244|PDB:1QH5}.
FT   STRAND      163    168       {ECO:0000244|PDB:1QH5}.
FT   STRAND      170    174       {ECO:0000244|PDB:1QH5}.
FT   STRAND      177    181       {ECO:0000244|PDB:1QH5}.
FT   HELIX       197    205       {ECO:0000244|PDB:1QH5}.
FT   TURN        206    210       {ECO:0000244|PDB:1QH5}.
FT   STRAND      216    221       {ECO:0000244|PDB:1QH5}.
FT   HELIX       224    234       {ECO:0000244|PDB:1QH5}.
FT   HELIX       239    254       {ECO:0000244|PDB:1QH5}.
FT   HELIX       263    269       {ECO:0000244|PDB:1QH5}.
FT   TURN        271    276       {ECO:0000244|PDB:1QH5}.
FT   HELIX       278    284       {ECO:0000244|PDB:1QH5}.
FT   HELIX       289    302       {ECO:0000244|PDB:1QH5}.
SQ   SEQUENCE   308 AA;  33806 MW;  64E5C214B6EC61CB CRC64;
     MVVGRGLLGR RSLAALGAAC ARRGLGPALL GVFCHTDLRK NLTVDEGTMK VEVLPALTDN
     YMYLVIDDET KEAAIVDPVQ PQKVVDAARK HGVKLTTVLT THHHWDHAGG NEKLVKLESG
     LKVYGGDDRI GALTHKITHL STLQVGSLNV KCLATPCHTS GHICYFVSKP GGSEPPAVFT
     GDTLFVAGCG KFYEGTADEM CKALLEVLGR LPPDTRVYCG HEYTINNLKF ARHVEPGNAA
     IREKLAWAKE KYSIGEPTVP STLAEEFTYN PFMRVREKTV QQHAGETDPV TTMRAVRREK
     DQFKMPRD
//
